candesartan has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition to treatment with prednisolone, they were administered anticoagulants(warfarin, or aspirin, or heparin) for APSN and an angiotensin II receptor blocker, candesartan, for the hypertension." | 3.71 | [Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis]. ( Kawakami, K; Komiya, T; Negoro, N; Okada, S; Okamura, M; Okazaki, M; Sumi, T; Tsukamoto, J; Yoshikawa, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komiya, T | 1 |
| Okamura, M | 1 |
| Kawakami, K | 1 |
| Okazaki, M | 1 |
| Tsukamoto, J | 1 |
| Okada, S | 1 |
| Sumi, T | 1 |
| Negoro, N | 1 |
| Yoshikawa, J | 1 |
1 other study available for candesartan and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
[Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis].
Topics: Adult; Angiotensin Receptor Antagonists; Anticoagulants; Antigen-Antibody Complex; Antihypertensive | 2002 |